Medical Disclaimer This article is for general education only
Additionally, GLP-1 drugs have been shown to lower the risk of major cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes, regardless of their impact on blood sugar levels
For healthcare professionals seeking to expand their scope, improve patient outcomes, and build a sustainable revenue stream, obesity medicine training offers a clear and compelling path forward
Patients who continue eating and exercising like they did while using GLP-1s typically maintain their weight loss results
Insurance coverage also plays a role phentermine is universally covered while GLP-1 coverage varies
CJC-1295 (No DAC) has been researched for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a shorter duration of action compared to DAC-bound variants